학술논문

COST-MINIMIZATION AND BUDGET IMPACT ANALYSIS OF VENETOCLAX VERSUS ACALABRUTINIB FOR 1L AND R/R CHRONIC LYMPHOCYTIC LEUKEMIA IN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM
Document Type
Journal
Source
VALUE IN HEALTH; JUN 2023, 26 6, pS69-pS69, 1p. Supplement: S
Subject
Language
English
ISSN
15244733